Table 2.
Clinical and laboratory finding in HIV positive patients.
| N | (%) | |
|---|---|---|
| Packed cell volume (PCV) | ||
| 20–29 | 28 | 50.0 |
| 30–39 | 25 | 44.6 |
| 40–50 | 3 | 5.4 |
| CD4 cell count (cells/µL) | ||
| >200 | 35 | 60.3 |
| 200–349 | 14 | 24.1 |
| 350–499 | 5 | 8.6 |
| ≥500 | 4 | 6.9 |
| Presence of opportunistic infections | ||
| PTB | 16 | 27.6 |
| Oral candidiasis | 4 | 6.9 |
| CNS toxoplasmosis | 2 | 3.5 |
| PTB + oral candidiasis | 6 | 10.3 |
| Herpes skin infection + PTB | 1 | 1.7 |
| None | 29 | 50.0 |
| WHO HIV stage | ||
| 1 | 5 | 8.6 |
| 2 | 11 | 19.0 |
| 3 | 36 | 62.0 |
| 4 | 6 | 10.3 |
| Weight (kg) | ||
| 30–39 | 6 | 11.1 |
| 40–49 | 16 | 29.6 |
| 50–59 | 21 | 38.9 |
| 60–69 | 9 | 16.7 |
| ≥70 | 2 | 3.7 |